chr19-50417838-G-A
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_002691.4(POLD1):c.3219-4G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000165 in 1,576,500 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_002691.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POLD1 | NM_002691.4 | c.3219-4G>A | splice_region_variant, intron_variant | Intron 26 of 26 | ENST00000440232.7 | NP_002682.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POLD1 | ENST00000440232.7 | c.3219-4G>A | splice_region_variant, intron_variant | Intron 26 of 26 | 1 | NM_002691.4 | ENSP00000406046.1 | |||
ENSG00000142539 | ENST00000599632.1 | c.425+569G>A | intron_variant | Intron 5 of 9 | 5 | ENSP00000473233.1 |
Frequencies
GnomAD3 genomes AF: 0.0000207 AC: 3AN: 144816Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000141 AC: 3AN: 213250Hom.: 0 AF XY: 0.0000172 AC XY: 2AN XY: 116268
GnomAD4 exome AF: 0.0000161 AC: 23AN: 1431684Hom.: 0 Cov.: 31 AF XY: 0.0000183 AC XY: 13AN XY: 711122
GnomAD4 genome AF: 0.0000207 AC: 3AN: 144816Hom.: 0 Cov.: 31 AF XY: 0.0000141 AC XY: 1AN XY: 70910
ClinVar
Submissions by phenotype
not specified Uncertain:1
- -
not provided Benign:1
- -
Colorectal cancer, susceptibility to, 10 Benign:1
- -
Hereditary cancer-predisposing syndrome Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at